Company Number: 14502293

Analysis Date: 2025-07-29 12:33 UTC

1. Risk Rating: LOW

The company is newly incorporated (Nov 2022) and has filed its first set of micro-entity accounts timely with no overdue filings. The balance sheet shows positive net current assets (£9,727) and shareholders' funds (£11,401), indicating solvency at the reporting date. The company has minimal fixed assets and a modest current asset base, consistent with a small, service-oriented business. No signs of regulatory non-compliance or governance issues are evident.

2. Key Concerns:

• Limited Financial History: With only one financial period reported, there is no track record for revenue stability or profitability trends.
• Modest Working Capital: Although positive, net current assets are relatively low, which may constrain liquidity if unexpected expenses arise.
• Single Employee and Director Control: The business relies heavily on the founder/director (Dr Benjamin Andrew Makin) who holds 75-100% ownership and voting rights, presenting concentration risk.

3. Positive Indicators:

• Timely Filing Compliance: Both accounts and confirmation statement filings are up to date, indicating good governance.
• Healthy Solvency Position: Positive net current assets and shareholders' funds suggest the company can meet short-term liabilities.
• Niche Professional Services: Operating in a specialized medical writing niche may support sustainable income streams if client acquisition is successful.

4. Due Diligence Notes:

• Verify revenue generation and cash flow beyond balance sheet snapshots to assess operational sustainability.
• Review director's business plan and pipeline for client acquisition to understand growth prospects.
• Confirm no undisclosed liabilities or contingent risks exist given limited financial history.
• Assess any related party transactions, considering director’s significant control.